Status:
TERMINATED
A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers
Lead Sponsor:
Achaogen, Inc.
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This is a randomized, double-blind, placebo-controlled, multiple-dose study, designed to assess the safety, tolerability, and pharmacokinetics (PK) of ACHN-975. This study will take place in the US at...
Eligibility Criteria
Inclusion
- Key
- Body weight between 40 and 100 kilograms (between \~88 pounds and \~220 pounds)
- Use of contraception
- Stable health
- Negative tests for alcohol, tobacco, and drugs of abuse
- Key
Exclusion
- History of clinically significant disease
- Pregnancy
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01870245
Start Date
May 1 2013
Last Update
July 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigational Site
Overland Park, Kansas, United States, 66211